Azenta, Inc. (AZTA) vs Palvella Therapeutics, Inc. (PVLA)

A side-by-side comparison of Azenta, Inc. and Palvella Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Azenta, Inc. logo
AZTA
Azenta, Inc.
$1.81B
$39.35HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Palvella Therapeutics, Inc. logo
PVLA
Palvella Therapeutics, Inc.
$1.84B
$128.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — AZTA vs PVLA

growth of $100 · dividends reinvested · last 2y
AZTA -5.0% (-2.6%/yr)PVLA +677.4% (+178.8%/yr)PVLA compounded faster over this window
Log scale — wide-divergence pair
101001kStart $10020252026$95$777
AZTA PVLA

AZTA vs PVLA: by the numbers

  • •PVLA is the larger company ($1.84B vs $1.81B market cap).
  • •Both run net losses; PVLA's is the smaller (0.00% vs -20.02% net margin).

Metrics side by side

Valuation

MetricAZTAPVLA
Forward P/E79.23N/A
P/S ratio2.95N/A
P/B ratio1.208.47
EV / EBITDA49.01N/A
FCF yield0.54%N/A

Profitability

MetricAZTAPVLA
Gross margin44.05%0.00%
Operating margin-3.49%0.00%
Net margin-20.02%0.00%
ROE-8.14%-28.45%
ROIC-1.33%-23.90%

Growth (annualized)

MetricAZTAPVLA
Revenue CAGR (5Y)4.82%N/A
Total return CAGR (5Y)-15.91%N/A

Go deeper

Full AZTA analysisFull PVLA analysisInteractive comparison tool

Dig into the metrics

Azenta ROEPalvella Therapeutics ROEAzenta operating marginPalvella Therapeutics operating marginAzenta revenue growthPalvella Therapeutics revenue growthAzenta free cash flowPalvella Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.